Regulatory Risk Management in Nanotechnology: Proactive Steps to Take Now for Security in the Future
27 September 2007
Foley is proud to introduce its Nanotechnology Web conference series, The Business of Nanotech. This series is designed to keep participants up-to-date on the latest developments in the field of nanotechnology and the impact of those developments across industries.
In this, our inaugural program, we discussed Regulatory Risk Management in Nanotechnology: Proactive Steps to Take Now for Security in the Future. Specific topics included:
- The future prospects for U.S. Environmental Protection Agency (EPA) and U.S. Food and Drug Administration (FDA) regulatory activity
- Developments in self-regulatory initiatives involving industry and consumer groups
- The effects of activist opposition on the regulatory process
- Potential paths forward for the regulatory process
- Regulatory initiatives in key international markets
Speakers
- Val Giddings, President and CEO, PrometheusAB
- Mark Mansour, Partner, Foley
- Michael R. Pontrelli, Partner, Foley
People
Related Insights
25 April 2024
On Trial
A Trial Lawyer’s Trial Lawyer: Paul Callan On Trial
In this episode of On Trial, host Christopher DeGennaro sits down with seasoned trial lawyer and CNN legal commentator Paul Callan, former deputy chief of the Brooklyn District Attorney’s Office, with 30 years’ experience as a trial lawyer.
25 April 2024
Health Care Law Today
New Favorable OIG Advisory Opinion Allows Patient Assistant Programs Funded by Drug Manufacturers
The Office of Inspector General recently issued a new favorable advisory opinion regarding patient assistance programs for 12 specific disease funds.
09 May 2024
Events
The FTC Noncompete Rule: Where Do We Go From Here?
On Tuesday, April 23, 2024, the Federal Trade Commission (FTC) voted to finalize a rule abolishing the vast majority of employee noncompetes across the United States.